Page 48 of 72
Animal Health News & Notes for November 25, 2009
printer friendly version ************************************ Brakke Consulting’s Animal Health News & Notes for November 25, 2009 Copyright © Brakke Consulting, Inc. Editor: Lynn Fondon, DVM, MBA ************************************ IN THE NEWS: Brakke news Animal Health Industry History Book earnings news Central Garden & Pet Pilgrims Pride Tyson Foods other news Boehringer Ingelheim Vetmedica Chanelle Veterinary DSM Immunovaccine Novozymes Pfizer Provimi Animal Nutrition India Quantum Immunologics Vetcare ************************************ LOOKING FOR HOLIDAY GIFT IDEAS? Copies of Brakke Consulting’s recently-published book chronicling the history of the US animal health industry are still available! Reasonably priced at $35 per copy, these gift-quality books make great holiday gifts for employees and clients. For more information on The U.S. Animal Health Industry: Its pioneers and legacy of innovation, visit our website at www.BrakkeConsulting.com or contact Jane Morgan at jmorgan@brakkeconsulting.com ************************************ COMPANY EARNINGS RELEASES > Central Garden & Pet Company announced full year results for the fourth quarter ended September 26, 2009. Net sales for the Pet Products segment in the quarter were $204 million, a decrease of 10% compared to the year ago period. (Business Wire) > Tyson Foods reported results for the full year ended October 3, 2009. The company reported a net loss of ($537 million) compared with a profit of $86 million in fiscal 2008.
;
November 25, 2009
Animal Health News & Notes for November 20, 2009
printer friendly version ************************************ Brakke Consulting’s Animal Health News & Notes for November 20, 2009 Copyright © Brakke Consulting, Inc. Editor: Lynn Fondon, DVM, MBA ************************************ IN THE NEWS: Brakke news Animal Health Industry History Book 2009 US Flea Control and Heartworm Markets report earnings news JBS Menu Foods Pet DRx PetSmart Webster other news Boehringer Ingelheim Vetmedica ImmunoPhotonics Imulan IRIS Int’l Neogen Pet Porte Pfizer PositiveID Putney Radio Systems Royer Wedgewood Pharmacy Wynnstay Youngs Animal Feed ************************************ LOOKING FOR HOLIDAY GIFT IDEAS? Copies of Brakke Consulting’s recently-published book chronicling the history of the US animal health industry are still available! Reasonably priced at $35 per copy, these gift-quality books make great holiday gifts for employees and clients. For more information on The U.S. Animal Health Industry: Its pioneers and legacy of innovation, visit our website at www.BrakkeConsulting.com or contact Jane Morgan at jmorgan@brakkeconsulting.com. ************************************ COMPANY EARNINGS RELEASES > Patterson Companies reported results for its second fiscal quarter ended Oct. 24. Sales for the Webster Veterinary division grew 30% to $161 million in the most recent quarter, largely due to its acquisition of Columbus Serum in October 2008. (AP) > Menu Foods Income Fund announced results for the third quarter that ended September 30. Sales for the quarter were CA$67
;
November 20, 2009
Animal Health News & Notes for November 13, 2009
printer friendly version ************************************ Brakke Consulting’s Animal Health News & Notes for November 13, 2009 Copyright © Brakke Consulting, Inc. Editor: Lynn Fondon, DVM, MBA ************************************ IN THE NEWS: Brakke news US Flea Control & Heartworm Markets 2009 – last week to receive early-order discount earnings news Bioniche Digital Angel other news Antech Diagnostics Bayer Digital Angel Imulan Oculus Innovative Sciences ************************************ COMING SOON US FLEA CONTROL AND HEARTWORM MARKETS 2009 UPDATE LAST WEEK FOR EARLY-BIRD DISCOUNT! Brakke Consulting will soon be publishing our 2009 report on the US Flea Control and Heartworm Markets. The report includes valuable information on the US market for small animal parasiticides including: – an overview of the veterinary and OTC flea control markets – Product descriptions, prices, and sales for the leading veterinary flea and heartworm products – Overview of advertising expenditures for veterinary flea and heartworm products The report also includes a 2009 survey of over 200 veterinarians regarding topics such as product usage, brand switching, the effect of the economy on product sale; the impact of product sales outside the veterinary clinic channel; and developing resistance to new-generation products. The report on the US Flea Control & Heartworm Markets will be available for a purchase price of $4,995 if ordered by
;
November 13, 2009
Animal Health News & Notes for November 6, 2009
printer friendly version ************************************ Brakke Consulting’s Animal Health News & Notes for November 6, 2009 Copyright © Brakke Consulting, Inc. Editor: Lynn Fondon, DVM, MBA ************************************ IN THE NEWS: Brakke news Cancer in Dogs and Cats 2009 US Flea Control & Heartworm Markets 2009 earnings news Alpharma Animal Health International ImmuCell MWI Ridley other news Aribex CAO Group Dentalaire DigiMed Fri-Ribe IDEXX Intervet/Schering-Plough Merck Merial Nutreco Pet BioTech Schering-Plough Scynexis SeaBuck Equine Sigma Biomedics ************************************ COMING SOON! US FLEA CONTROL AND HEARTWORM MARKETS 2009 UPDATE ORDER NOW FOR EARLY-BIRD DISCOUNT Brakke Consulting will soon be publishing our 2009 report on the US Flea Control and Heartworm Markets. The report includes valuable information on the US market for small animal parasiticides including: – an overview of the veterinary and OTC flea control markets – Product descriptions, prices, and sales for the leading veterinary flea and heartworm products – Overview of advertising expenditures for veterinary flea and heartworm products The report also includes a 2009 survey of over 200 veterinarians regarding topics such as product usage, brand switching, the effect of the economy on product sale; the impact of product sales outside the veterinary clinic channel; and developing resistance to new-generation products. The report on the US Flea Control & Heartworm
;
November 6, 2009
Animal Health News & Notes for October 30, 2009
printer friendly version ************************************ Brakke Consulting’s Animal Health News & Notes for October 30, 2009 Copyright © Brakke Consulting, Inc. Editor: Lynn Fondon, DVM, MBA ************************************ IN THE NEWS: Brakke news Cancer in Dogs and Cats earnings news ABAXIS Bayer Heska Hill’s Merial other news AgriLabs Animal Element Boehringer Ingelheim Vetmedica Eco Intervet/Schering-Plough Merck Modern Veterinary Therapeutics Pharma Chemie Schering-Plough TR BioSurgical Vedco ************************************ NOW AVAILABLE! BRAKKE CONSULTING, INC. 2009 CANCER IN DOGS AND CATS In 2002, Brakke Consulting published an overview of the treatment of cancer in dogs and cats. We are pleased to announce that an update of this highly regarded report is now available. The 2009 Cancer Study includes up-to-the-minute information on the incidence, diagnosis, and treatment of the common veterinary cancers, including treatment cost estimates. The study includes a survey of over 200 general veterinary practitioners as well as interviews with veterinary oncologists. Reviews of new and developing veterinary cancer chemotherapeutics are included in the report as well. The report is now available for $8,500. For more information, please visit our website at www.BrakkeConsulting.com or contact Dr. Lynn Fondon at lfondon@brakkeconsulting.com . ******************** COMPANY EARNINGS RELEASES > Sanofi-Aventis reported results for the third quarter of 2009. Animal health division Merial’s third-quarter sales were flat, falling by
;
October 30, 2009
New report sheds light on veterinary oncology market
A new study from Brakke Consulting offers a look into the #1 killer of dogs and cats: cancer. ”Oncology is one of the highest interest areas in veterinary medicine today,” said Lynn Fondon, senior consultant of Brakke Consulting. “The report is particularly timely, considering that the first-ever FDA-approved veterinary chemotherapy drug was approved just a few months ago.” The study, Cancer in Dogs and Cats, provides information on the incidence of cancer in pets, examines how cancer is diagnosed and treated in veterinary medicine, and offers estimated costs for treatment. New and developing veterinary cancer products, including therapies and diagnostics, are also presented in the report. “Our veterinary survey found that despite costs that can reach thousands of dollars, many dog and cat owners are willing to pursue treatment when their pets are diagnosed with cancer,” comments Dr. Fondon. The report – the second edition of a study first fielded in 2002 – gathered information from a wide variety of sources, including published literature, specialist interviews, and a survey of 200 small animal veterinarians. Cancer in Dogs and Cats is available from Brakke Consulting for $8,500. For more information, interested companies should contact Lynn Fondon at 972.243.4033. About Brakke Consulting Brakke Consulting is the leading consulting firm specializing in the animal health and nutrition markets. It is located at 2735
;
October 23, 2009
Animal Health News & Notes for October 23, 2009
printer friendly version ************************************ Brakke Consulting’s Animal Health News & Notes for October 23, 2009 Copyright © Brakke Consulting, Inc. Editor: Lynn Fondon, DVM, MBA ************************************ IN THE NEWS: Brakke news AnimalHealthJobs.com Due Diligence Seminar earnings news Elanco IDEXX Intervet/Schering-Plough Nestle OurPet’s Company PetMed Express Pfizer Pilgrim’s Pride VCA Antech other news Alltech Hill’s KeySource Medical Merck PETCO Schering-Plough Trupanion ************************************ BRAKKE CONSULTING, INC. DUE DILIGENCE SEMINAR OCTOBER 27 – 28, 2009 KANSAS CITY There’s still time to register! Brakke Consulting announces a two day seminar covering the details of due diligence, a key element in the successful acquisition of companies, assets and intellectual property. The seminar is designed to increase a company’s probability of success in a purchase or sale by providing the details to ensure that all the important phases of the due diligence process are included. Speakers at the Brakke seminar will include Ron Brakke, John Mannhaupt and Joel Adamson, Brakke personnel who are well experienced in due diligence, as well as outside speakers from the finance industry and the legal profession. For more information on the seminar or to register, visit our website at www.BrakkeConsulting.com ******************** COMPANY EARNINGS RELEASES > Schering-Plough reported results for the third quarter of 2009. Intervet/Schering-Plough sales totaled $669 million in the
;
Animal Health News & Notes for October 16, 2009
printer friendly version ************************************ Brakke Consulting’s Animal Health News & Notes for October 16, 2009 Copyright © Brakke Consulting, Inc. Editor: Lynn Fondon, DVM, MBA ************************************ IN THE NEWS: Brakke news Due Diligence Seminar earnings news KMG Chemicals Vetoquinol Virbac other news AgriLabs Animal Health Options Eli Lilly Genitrix Hypor JBS KMG Chemicals LSG Health Systems Megastarter Merial Neogen Oragenics PetAg Pfizer Pilgrim’s Pride Vetoquinol Wyeth ************************************ BRAKKE CONSULTING, INC. DUE DILIGENCE SEMINAR OCTOBER 27 – 28, 2009 KANSAS CITY Brakke Consulting announces a two day seminar covering the details of due diligence, a key element in the successful acquisition of companies, assets and intellectual property. The seminar is designed to increase a company’s probability of success in a purchase or sale by providing the details to ensure that all the important phases of the due diligence process are included. Speakers at the Brakke seminar will include Ron Brakke, John Mannhaupt and Joel Adamson, Brakke personnel who are well experienced in due diligence, as well as outside speakers from the finance industry and the legal profession. For more information on the seminar or to register, visit our website at www.BrakkeConsulting.com ******************** COMPANY EARNINGS RELEASES > Virbac SA reported results for the third quarter of 2009. Net sales were EUR 122
;
October 16, 2009
Animal Health News & Notes for October 9, 2009
printer friendly version ************************************ Brakke Consulting’s Animal Health News & Notes for October 9, 2009 Copyright © Brakke Consulting, Inc. Editor: Lynn Fondon, DVM, MBA ************************************ IN THE NEWS: Brakke news Due Diligence Seminar Cancer in Dogs and Cats report – last week for discount! Equine Market Megastudy II other news Abaxis Alltech DermaPet IDEXX Neogen Nutramax Labs Nutro PurinaCare Insurance Services Ridley Venomix Vestaron *********************************** NEW STUDY: CANCER IN DOGS AND CATS LAST WEEK FOR EARLY-ORDER DISCOUNT In 2002, Brakke Consulting published an overview of the treatment of cancer in dogs and cats. We are pleased to announce that an update of this highly regarded report will be completed in October 2009. The 2009 Cancer Study will include up-to-the-minute information on the incidence, diagnosis and treatment of the common veterinary cancers. The study includes a survey of over 200 general veterinary practitioners as well as interviews with veterinary oncologists. Reviews of new and developing veterinary cancer chemotherapeutics are included in the report as well. The report is priced at $8,500, but pre-publication orders placed by October 16 will be eligible for a discounted price of $7,000. For more information, please visit our website at www.BrakkeConsulting.com or contact Dr. Lynn Fondon at lfondon@brakkeconsulting.com . ************************************ COMPANY NEWS RELEASES >
;
October 9, 2009
Animal Health News & Notes for October 2, 2009
printer friendly version ************************************ Brakke Consulting’s Animal Health News & Notes for October 2, 2009 Copyright © Brakke Consulting, Inc. Editor: Lynn Fondon, DVM, MBA ************************************ IN THE NEWS: Brakke news Due Diligence seminar Equine Market Megastudy II Cancer in Dogs & Cats report other news Bimeda BioElectronics CEVA ECAT Intervet/Schering-Plough (Merial) Intervet/Schering-Plough (Vectin) MBF Therapeutics Merial Pfizer Virbac ************************************ BRAKKE CONSULTING, INC. DUE DILIGENCE SEMINAR OCTOBER 27 – 28, 2009 KANSAS CITY ONLINE REGISTRATION NOW AVAILABLE Brakke Consulting announces a two day seminar covering the details of due diligence, a key element in the successful acquisition of companies, assets and intellectual property. The seminar is designed to increase a company’s probability of success in a purchase or sale by providing the details to ensure that all the important phases of the due diligence process are included. Speakers at the Brakke seminar will include Ron Brakke, John Mannhaupt and Joel Adamson, Brakke personnel who are well experienced in due diligence, as well as outside speakers from the finance industry and the legal profession. For more information on the seminar or to register, visit our website at www.BrakkeConsulting.com ************************************ COMPANY NEWS RELEASES > Sanofi-Aventis SA is likely to exercise its option to create a massive animal health joint venture with Merck & Co,
;
October 2, 2009
Animal Health News & Notes for September 25, 2009
printer friendly version ************************************ Brakke Consulting’s Animal Health News & Notes for September 25, 2009 Copyright © Brakke Consulting, Inc. Editor: Lynn Fondon, DVM, MBA ************************************ IN THE NEWS: earnings news Bioniche Neogen other news Boehringer Ingelheim Vetmedica CEVA DRE Veterinary Fort Dodge Hipra Lallemand Pets Best Insurance Pfizer SA Bioproducts *********************************** NEW BRAKKE CONSULTING STUDY: EQUINE MARKET MEGASTUDY II NOW AVAILABLE! A comprehensive new national survey of 1,000 US horse owners for the first time estimates the market size for more than a dozen categories of widely used products. It also shows that the current US recession has had a material, negative impact on horse ownership and product sales. The study, Equine Market MegaStudy II, includes more than 400 brands in 14 separate product categories. It examined what brands were purchased, how often they were purchased, where they were purchased, and the amount of money spent. The 200-page report also includes extensive data on horse owner demographics, media usage, event participation and shopping habits. The research was conducted by Brakke Consulting and The Pert Group (a recent merger of Market Directions, Pert Survey Research and Pulsar Research and Consulting). Equine Market MegaStudy II is now available for $9,900. For more information or to order a report, visit our website or contact
;
September 25, 2009
Brakke announces publication of Equine Market Megastudy II
A comprehensive new survey of US horse owners for the first time estimates the size of the market for more than a dozen categories of widely used products. It also shows that the current US recession had had a material, negative impact on horse ownership and product sales. The study, Equine Market MegaStudy II, is based on lengthy interviews with a national sample of more than 1,000 horse owners on products and brands purchased in the last year. The study was conducted by Brakke Consulting, Inc, and The Pert Group. The research includes more than 400 brands in 14 separate product categories. It examined what brands were purchased, how often they were purchased, where they were purchased, and the amount of money spent. “Equine Market MegaStudy II is the second edition of a study first fielded in 2006. Comparing the two studies clearly illustrates shifts in product use and brand preferences,” said John Volk, senior consultant of Brakke Consulting. “In this new edition, we were able to project size of market at the retail level for a large number of products.” “Because of the timing of the 2009 study, we included specific questions about the impact of the recession. The economic downturn has had a significant impact on horse ownership and purchases,” said Susan Spaulding, partner with The Pert Group.
;
September 18, 2009
Animal Health News & Notes for September 18, 2009
printer friendly version ************************************ Brakke Consulting’s Animal Health News & Notes for September 18, 2009 Copyright © Brakke Consulting, Inc. Editor: Lynn Fondon, DVM, MBA ************************************ IN THE NEWS: earnings news Genus other news AgraQuest Alpharma AP Pharma Bertin BioArts Int’l Biogénesis Bagó Elanco Global Animal Mgmt JBS (Bertin) JBS (Pilgrims Pride) Mars Veterinary Merial (AP Pharma) Merial (sanofi acquisition) Merial (Scarab) Nutro Pfizer (derquantel) Pfizer (Trocoxil) Pilgrim’s Pride PRN Pharmacal Sanomedics Sarnoff Scarab Genomics Smithfield Foods *********************************** NEW BRAKKE CONSULTING STUDY: CANCER IN DOGS AND CATS COMING IN OCTOBER In 2002, Brakke Consulting published an overview of the treatment of cancer in dogs and cats. We are pleased to announce that an update of this highly regarded report will be completed in October 2009. The 2009 Cancer Study will include up-to-the-minute information on the incidence and treatment of the common veterinary cancers. The study includes a survey of over 200 general veterinary practitioners as well as interviews with veterinary oncologists. Reviews of new and developing veterinary cancer chemotherapeutics are included in the report as well. The report is priced at $8,500, but pre-publication orders placed by October 16 will be eligible for a discounted price of $7,000. For more information, please visit our website at www.BrakkeConsulting.com or contact Dr. Lynn Fondon
;
Animal Health News & Notes for September 11, 2009
printer friendly version ************************************ Brakke Consulting’s Animal Health News & Notes for September 11, 2009 Copyright © Brakke Consulting, Inc. Editor: Lynn Fondon, DVM, MBA ************************************ IN THE NEWS: earnings news Smithfield Foods other news Cargill Dopharma Freshpet Global Animal Mgmt IGENITY Intervet/Schering-Plough Lloyd Novartis Virbac *********************************** BRAKKE CONSULTING, INC. DUE DILIGENCE SEMINAR OCTOBER 27 – 28, 2009 KANSAS CITY Brakke Consulting announces a two day seminar covering the details of due diligence, a key element in the successful acquisition of companies, assets and intellectual property. The seminar is designed to increase a company’s probability of success in a purchase or sale by providing the details to ensure that all the important phases of the due diligence process are included. Speakers at the Brakke seminar will include Ron Brakke, John Mannhaupt and Joel Adamson, Brakke personnel who are well experienced in due diligence, as well as outside speakers from the finance industry and the legal profession. For more information on the seminar, visit our website at www.BrakkeConsulting.com *********************************** COMPANY EARNINGS RELEASES > Smithfield Foods Inc. announced a loss of ($108 million) for its first fiscal 2010 quarter compared with a loss of ($29 million) in its first fiscal 2009 quarter. Smithfield attributed its loss primarily to a $162 million loss in
;
September 11, 2009
Animal Health News & Notes for September 4, 2009
printer friendly version ************************************ Brakke Consulting’s Animal Health News & Notes for September 4, 2009 Copyright © Brakke Consulting, Inc. Editor: Lynn Fondon, DVM, MBA ************************************ IN THE NEWS: earnings news Animal Health Int’l Dechra Del Monte Ridley other news JBS Merck Norbrook Labs Pilgrims Pride Schering-Plough Spectrum Brands *********************************** BRAKKE CONSULTING, INC. ANNOUNCES LAUNCH OF NEW BOOK ON US ANIMAL HEALTH INDUSTRY Brakke Consulting is pleased to announce the launch of The US Animal Health Industry: Its pioneers and legacy of innovation. The book documents the history of the companies and associations that significantly impacted the evolution and growth of the animal health industry, and captures the voices of many of the principal players in the industry’s early days. The book is now available for ordering at $35.00 per copy (plus shipping & handling). For more information, visit our website at www.BrakkeConsulting.com *********************************** COMPANY EARNINGS RELEASES > Dechra Pharmaceuticals reported results for the fiscal year ended June 30, 2009. Total revenue was GBP 350 million ($578 million), an increase of 15% compared to the prior year. Pharmaceuticals division revenue was GBP 85 million ($140 million), an increase of 57% compared to the prior year; this included the full year effect of the acquisition of VetXX in January 2008. (company website)
;
September 4, 2009
Animal Health News & Notes for August 28, 2009
printer friendly version ************************************ Brakke Consulting’s Animal Health News & Notes for August 28, 2009 Copyright © Brakke Consulting, Inc. Editor: Lynn Fondon, DVM, MBA ************************************ IN THE NEWS: earnings news Provimi Sanderson Farms other news Bertin Bio Agri Mix Chr. Hansen MGP Ingredients Phibro Royal Canin Sergeant’s *********************************** BRAKKE CONSULTING, INC. ANNOUNCES LAUNCH OF NEW BOOK ON US ANIMAL HEALTH INDUSTRY Brakke Consulting is pleased to announce the launch of The US Animal Health Industry: Its pioneers and legacy of innovation. The book documents the history of the companies and associations that significantly impacted the evolution and growth of the animal health industry, and captures the voices of many of the principal players in the industry’s early days. The book is now available for ordering at $35.00 per copy (plus shipping & handling). For more information, visit our website at www.BrakkeConsulting.com *********************************** COMPANY EARNINGS RELEASES > The Provimi Group reported results for the first half of 2009. Revenues were EUR 841 million ($1,181 million), a decrease of 23% compared to revenues in the first half of 2008. On a like-for-like basis, the sales decrease was 17%. Net loss was (EUR 54 million) compared to a net income of EUR 50 million in the first half of 2008. (company press release)
;
August 28, 2009
Brakke Consulting Launches Book Documenting History of the US Animal Health Industry
A new book, “The U.S. Animal Health Industry: Its Pioneers and Legacy of Innovation,” was unveiled at the annual Homecoming Dinner and Networking Event held in Kansas City today. The book was developed by Brakke Consulting, Inc., and published by Advanstar Communications, Inc. The Homecoming Dinner is a special event sponsored by the Kansas City Animal Health Corridor for animal health industry executives and held in conjunction with CVC Central, a veterinary conference held annually in Kansas City. “One of the primary reasons for publishing this book was to capture the voices of many of the principal players in the early days of the industry while they were still available to tell their stories,” said Ron Brakke, president of Brakke Consulting. In the late 19th century hog cholera wiped out 10 percent of the U.S. swine population. The fight against hog cholera was the seminal event that launched the animal health industry. The cure required unprecedented levels of scientific research and the development, regulatory approval, and delivery of innovative products. This became the foundation for today’s $6 billion industry. “The book documents the history of the individuals, companies, associations and distributors that played key roles in moving the industry from its beginnings to the present day. It includes several interviews with some of the early pioneers,” Brakke said. Book chapter
;
Animal Health News & Notes for August 21, 2009
printer friendly version ************************************ Brakke Consulting’s Animal Health News & Notes for August 21, 2009 Copyright © Brakke Consulting, Inc. Editor: Lynn Fondon, DVM, MBA ************************************ IN THE NEWS: earnings news Cargill PetSmart Webster other news Bio-Vet IDEXX Medivet Pet Valu VDIC *********************************** BRAKKE CONSULTING, INC. DUE DILIGENCE SEMINAR OCTOBER 27 – 28, 2009 KANSAS CITY Brakke Consulting announces a two day seminar covering the details of due diligence, a key element in the successful acquisition of companies, assets and intellectual property. The seminar is designed to increase a company’s probability of success in a purchase or sale by providing the details to ensure that all the important phases of the due diligence process are included. Speakers at the Brakke seminar will include Ron Brakke, John Mannhaupt and Joel Adamson, Brakke personnel who are well experienced in due diligence, as well as outside speakers from the finance industry and the legal profession. For more information, visit our website at www.BrakkeConsulting.com *********************************** COMPANY EARNINGS RELEASES > Patterson Companies, Inc. reported results for the first quarter of fiscal 2010 ended July 25. Sales of the Webster Veterinary unit increased 37% to $169 million. Internal growth accounted for 8% of this increase, with the October 2008 acquisition of Columbus Serum Company accounting for the
;
August 21, 2009
Animal Health News & Notes for August 14, 2009
printer friendly version ************************************ Brakke Consulting’s Animal Health News & Notes for August 14, 2009 Copyright © Brakke Consulting, Inc. Editor: Lynn Fondon, DVM, MBA ************************************ IN THE NEWS: earnings news CEVA Heska JBS Nestle Spectrum Brands other news AnimalScan Arenus Elanco Equilite Iams Pet Imaging Merck MWI Schering-Plough VetCentric *********************************** BRAKKE CONSULTING, INC. NEW ANIMAL HEALTH SALARY COMPENSATION SURVEY Brakke Consulting is planning to conduct a Compensation Survey covering several levels of animal health employees. The survey will include employees in five departments plus General Management. It is designed to be specific to current compensation levels in animal health. If your company is interested in participating, please contact John Mannhaupt at jmannhaupt@brakkeconsulting.com *********************************** COMPANY EARNINGS RELEASES > CEVA Sante Animale reported results for the full year 2008 and the first six months of 2009. In the 2008 financial year, the CEVA Group recorded sales of EUR 377 million ($530 million), a 7% increase compared to 2007 (8% at constant perimeter and exchange rates). In the first half of 2009, Ceva’s sales grew by 4% to EUR 185 million ($260 million). (Animal Pharm) > Heska reported results for the second quarter of 2009. Total revenues were $18.6 million, a decline of 18% compared to the second quarter of 2008. Net income was
;
August 14, 2009
Brakke Consulting Announces Due Diligence Seminar
A special two-day seminar on how to conduct due diligence effectively will be held in Kansas City on October 27-28. It will be conducted by executives from Brakke Consulting, Inc. “Good due diligence is critical to the success of financial transactions such as acquisitions and licensing agreements,” said Ron Brakke, president of Brakke Consulting. “This hands-on seminar provides a proven template for conducting due diligence thoroughly and successfully.” The seminar will be held at Brakke Consulting’s offices in the Enterprise Center of Johnson County, 8527 Bluejacket Street, Lenexa, Kansas, beginning at 8:00 AM on October 27. The seminar will conclude by 3:30 PM on October 28. Cost of the seminar is $1,375 per person. Registration is limited to 32 attendees. Presenters include three Brakke consultants with extensive due diligence experience – Ron Brakke, John Mannhaupt and Joel Adamson – as well as experts in finance and law. “Seminar content will aid participants in uncovering issues that could result in costly problems. It will also help companies in finding added value in acquisitions that fit with their strategies,” Brakke added. Brakke Consulting, the leading management consulting firm serving the animal health and nutrition industries. Established in 1986, Brakke Consulting provides a full range of consulting services, including assistance with general business issues, acquisitions and divestitures, market research, executive search, and veterinary
;
Page 48 of 72
English 
Portuguese 
Japanese 
Chinese